• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Peripheral blood interleukin 6, interleukin 10, and T lymphocyte levels are associated with checkpoint inhibitor induced pneumonitis: a case report.

作者信息

McCallen Justin D, Naqash Abdul Rafeh, Marie Mona A, Atwell Druid C, Muzaffar Mahvish, Sharma Nitika, Amara Suneetha, Liles Darla, Walker Paul R, Yang Li V

机构信息

Brody School of Medicine, East Carolina University, Greenville, NC, USA.

Gastrointestinal Malignancy Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

Acta Oncol. 2021 Jun;60(6):813-817. doi: 10.1080/0284186X.2021.1917001. Epub 2021 May 3.

DOI:10.1080/0284186X.2021.1917001
PMID:33939588
Abstract
摘要

相似文献

1
Peripheral blood interleukin 6, interleukin 10, and T lymphocyte levels are associated with checkpoint inhibitor induced pneumonitis: a case report.外周血白细胞介素6、白细胞介素10和T淋巴细胞水平与检查点抑制剂诱发的肺炎相关：病例报告
Acta Oncol. 2021 Jun;60(6):813-817. doi: 10.1080/0284186X.2021.1917001. Epub 2021 May 3.
2
Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor.外周血 PD1 阳性 CD4 T 淋巴细胞计数可预测接受免疫检查点抑制剂治疗的非小细胞肺癌患者的无进展生存期。
Anticancer Res. 2019 Dec;39(12):6887-6893. doi: 10.21873/anticanres.13908.
3
Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer.非小细胞肺癌患者免疫检查点抑制剂相关肺炎的特征、发生率和危险因素。
Lung Cancer. 2018 Nov;125:150-156. doi: 10.1016/j.lungcan.2018.09.015. Epub 2018 Sep 18.
4
High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review.纳武利尤单抗致肺炎的高发生率和早发性：4 例病例报告及文献复习。
BMC Pulm Med. 2018 Jan 30;18(1):23. doi: 10.1186/s12890-018-0592-x.
5
Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report.尼达尼布允许在因阿特珠单抗引起的肺炎后，对联合非小细胞肺癌/特发性肺纤维化用阿特珠单抗进行重新治疗：一例报告。
BMC Pulm Med. 2019 Aug 22;19(1):156. doi: 10.1186/s12890-019-0920-9.
6
A Wake-Up Call for Immune Checkpoint Inhibitor-Related Pneumonitis.免疫检查点抑制剂相关肺炎的警钟
J Thorac Oncol. 2021 Sep;16(9):1440-1442. doi: 10.1016/j.jtho.2021.06.001.
7
Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.基线外周血嗜酸性粒细胞计数与免疫检查点抑制剂相关肺炎及免疫检查点抑制剂治疗非小细胞肺癌患者临床结局的相关性。
Lung Cancer. 2020 Dec;150:76-82. doi: 10.1016/j.lungcan.2020.08.015. Epub 2020 Aug 23.
8
Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis.一例致命性免疫检查点抑制剂相关性肺炎的放射学及尸检结果
Cancer Treat Res Commun. 2018;15:17-20. doi: 10.1016/j.ctarc.2018.02.004. Epub 2018 Feb 21.
9
Multidisciplinary Approach of Immune Checkpoint Inhibitor-Related Pneumonitis: A Key to Address Knowledge and Management Gaps.免疫检查点抑制剂相关肺炎的多学科方法：解决知识与管理差距的关键
J Thorac Oncol. 2020 Aug;15(8):1261-1264. doi: 10.1016/j.jtho.2020.05.007.
10
Clinical course and prognosis of patients with lung cancer who develop anticancer therapy-related pneumonitis.癌症治疗相关肺炎患者的临床病程和预后。
J Cancer Res Clin Oncol. 2021 Jun;147(6):1857-1864. doi: 10.1007/s00432-020-03478-2. Epub 2021 Jan 2.

引用本文的文献

1
Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management.免疫检查点抑制剂相关性肺炎：预测和管理方面的研究进展。
Front Immunol. 2024 Feb 15;15:1266850. doi: 10.3389/fimmu.2024.1266850. eCollection 2024.
2
Case Report: Peripheral blood T cells and inflammatory molecules in lung cancer patients with immune checkpoint inhibitor-induced thyroid dysfunction: Case studies and literature review.病例报告：免疫检查点抑制剂诱导的甲状腺功能障碍的肺癌患者外周血T细胞和炎症分子：病例研究与文献综述
Front Oncol. 2022 Dec 7;12:1023545. doi: 10.3389/fonc.2022.1023545. eCollection 2022.
3
Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis.
单细胞转录组学鉴定出免疫检查点抑制剂相关肺炎中的致病性辅助性 T 细胞 17.1 细胞和促炎单核细胞。
J Immunother Cancer. 2022 Sep;10(9). doi: 10.1136/jitc-2022-005323.
4
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis.拟议的临床阶段，以改善免疫检查点抑制剂相关肺炎的个体化治疗。
Front Immunol. 2022 Jul 20;13:935779. doi: 10.3389/fimmu.2022.935779. eCollection 2022.